Lung Cancer Clinical Trial

Decision Aid for the Improvement of Decision-Making in Patients With Non-small Cell Lung Cancer

Summary

This clinical trial refines and tests the effect of a decision aid in improving decision-making in patients with non-small cell lung cancer. Patients with cancer want to be informed about their diagnoses, treatment procedures and goals of treatment. They also seek active roles in decision-making. Shared decision-making (SDM) is the process of clinician and patient jointly participating in a health decision after discussing the options, benefits and harms, and considering the patient's values, preferences, and circumstances. SDM can improve patient involvement in decision making, satisfaction, health care quality, and quality of life. Decision aids can improve patient knowledge, create more realistic outcome expectations; reduce decisional conflict, distress, depression and uncertainty; and improve physician-patient communication and quality of life, compared with no decision aid. This trial's main aim is to evaluate the feasibility and efficacy of a decision aid in patients with non-small cell lung cancer.

View Full Description

Full Description

PRIMARY OBJECTIVES:

I. Refine a conversation tool among patients with lung cancer by conducting prototype testing in an iterative process.

II. Conduct a trial at two comprehensive cancer treatment centers representing academic and Veterans Affairs medical centers.

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM I: Patients receive the conversation tool.

ARM II: Patients receive usual care.

Patients in both arms are followed up within 4-8 weeks after baseline to complete a second questionnaire.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

PART I: Completed treatment for suspected or confirmed stage I-IV non-small cell lung cancer (NSCLC)
PART I: English fluency
PART II: Undergoing diagnostic work-up for suspected stage I-IV NSCLC
PART II: English fluency
PART II: > 6-month life expectancy
PART II: Score of > 3 on the 6-Item Screener for Cognitive Impairment

Study is for people with:

Lung Cancer

Estimated Enrollment:

65

Study ID:

NCT04946279

Recruitment Status:

Active, not recruiting

Sponsor:

OHSU Knight Cancer Institute

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

OHSU Knight Cancer Institute
Portland Oregon, 97239, United States
Portland VA Medical Center
Portland Oregon, 97239, United States

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

65

Study ID:

NCT04946279

Recruitment Status:

Active, not recruiting

Sponsor:


OHSU Knight Cancer Institute

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.